Buy Vilon Regenerative Support Supplier

PX1 Research provides certified, ultra-pure Vilon (Lys-Glu) dipeptide engineered strictly for non-clinical laboratory research and controlled in vitro assays. Institutional investigators rely on our USA-manufactured reagents to explore chromatin remodeling, gene expression, and bio-regulatory signaling with complete analytical transparency.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

PX1 Research provides certified, ultra-pure Vilon (Lys-Glu) dipeptide engineered strictly for non-clinical laboratory research and controlled in vitro assays. Institutional investigators rely on our USA-manufactured reagents to explore chromatin remodeling, gene expression, and bio-regulatory signaling with complete analytical transparency.

Reviewed by PX1 Research scientific team

Key takeaways

  • When evaluating a buy vilon regenerative support supplier for preclinical investigation, institutional researchers require verifiable chemical identity, analytical purity exceeding 98% via RP-HPLC, mass spectrometry validation, and documented endotoxin limits.
  • Vilon is a synthetic short-chain dipeptide with the chemical sequence Lysyl-Glutamic acid (H-Lys-Glu-OH).
  • In vitro data indicate that Vilon operates primarily through epigenetic pathways rather than classic membrane receptor transactivation.
  • Preclinical investigation into Vilon's regenerative potential spans multiple rodent models evaluating tissue repair, immune reconstitution, and cellular longevity.

Sourcing High-Purity Vilon for Laboratory Research: Quick Overview

When evaluating a buy vilon regenerative support supplier for preclinical investigation, institutional researchers require verifiable chemical identity, analytical purity exceeding 98% via RP-HPLC, mass spectrometry validation, and documented endotoxin limits. PX1 Research supplies USA-manufactured, research-grade Vilon dipeptide accompanied by comprehensive lot-specific Certificates of Analysis (COAs) to support reproducible scientific inquiry across cell culture and animal models.

As an ultra-short regulatory peptide consisting of L-lysine and L-glutamic acid, Vilon presents unique biochemical properties that necessitate precise synthetic execution and stringent quality control. Obtaining research compounds from verified domestic suppliers ensures that experimental assays regarding chromatin activation, transcription factor binding, and cellular senolytic dynamics remain unconfounded by impurities, heavy metals, or residual synthesis reagents.

Molecular Structure and Biochemical Profile of Vilon (Lys-Glu)

Vilon is a synthetic short-chain dipeptide with the chemical sequence Lysyl-Glutamic acid (H-Lys-Glu-OH). Featuring a molecular weight of approximately 275.31 g/mol, its minimal steric footprint allows it to interact directly with nuclear structures and specific DNA sequence domains without requiring complex receptor-mediated internalization mechanisms typical of larger polypeptide ligands.

In chemical literature, Vilon is categorized alongside short peptide bioregulators derived from thymic tissue extracts. Its basic amine residue (Lysine) coupled with an acidic carboxyl group (Glutamic acid) creates a zwitterionic dynamic at physiological pH. This unique electrostatic configuration facilitates tight binding to the minor groove of double-stranded DNA, influencing histone acetylation states and chromatin condensation in preclinical cell culture models.

Researchers investigating the broad catalogue of synthetic research peptides frequently examine Vilon due to its structural simplicity and stability under standard laboratory storage protocols. Understanding its basic chemical parameters enables precise concentration calculations when preparing working stock solutions for quantitative downstream assays.

Preclinical Mechanisms: Epigenetic Remodeling and Chromatin Dynamics

In vitro data indicate that Vilon operates primarily through epigenetic pathways rather than classic membrane receptor transactivation. Experiments using cultured human lymphocytes and fibroblast lines demonstrate that the dipeptide induces decondensation of pericentromeric heterochromatin. By promoting an open chromatin conformation (euchromatin), Vilon enhances accessibility for RNA polymerase complexes, thereby altering transcriptional activity across targeted gene loci.

Animal studies suggest that Vilon modulates the expression of key cellular regulatory proteins, including markers associated with ribosomal RNA synthesis, heat shock responses, and anti-oxidative enzyme pathways. Preclinical models evaluating age-associated gene silencing have recorded restored transcription of ribosomal genes following exposure to Lys-Glu, pointing to a direct role in maintaining nucleolar functional integrity.

Additionally, non-clinical research highlights Vilon's capacity to influence cytokine expression profiles in isolated immune cell populations. In vitro models show modulation of interleukin-2 (IL-2) expression and lymphocyte reactivation without triggering hyper-inflammatory signaling cascades, making it a critical tool for researchers studying baseline immune senescence and cellular homeostasis within our broader peptide research database.

In Vitro and Animal Model Evidence: Regenerative & Geroprotective Studies

Preclinical investigation into Vilon's regenerative potential spans multiple rodent models evaluating tissue repair, immune reconstitution, and cellular longevity. In rodent models of accelerated aging, administration of Vilon was observed to reduce the incidence of spontaneous tumor formation while normalizing lipid metabolic parameters and structural markers of organ tissue degradation.

In vitro assays focusing on cutaneous fibroblast cultures demonstrate that Vilon exposure stimulates cell proliferation and enhances collagen synthesis metrics. Researchers have noted accelerated wound closure rates in rodent models, linked to elevated extracellular matrix remodeling and enhanced microvascular stabilization within the lesion site.

Furthermore, rodent studies investigating cardiovascular and neuronal tissue resilience indicate that Vilon exerts protective effects against oxidative-stress-induced apoptosis. By stabilizing mitochondrial membrane potential and modulating caspase-3 activation pathways, the dipeptide supports cellular survival under hypoxic or oxidative challenges in laboratory environments.

Comparative Analysis: Vilon vs. Epitalon, Thymogen, and BPC-157

To properly contextualize Vilon within comparative preclinical frameworks, researchers often contrast its structural and functional metrics with other bioregulatory short peptides. While Vilon (Lys-Glu) focuses heavily on chromatin structural modification and basic immune cell activation, related synthetic compounds demonstrate overlapping yet distinct organ-specific targets.

For instance, Epitalon research centers on pineal gland regulation, telomerase activity upregulation, and circadian rhythm entrainment, offering a broader systemic geroprotective profile than Vilon alone. Conversely, Thymogen pathways focus specifically on T-cell differentiation markers, functioning as a targeted immunomodulator. In models of structural tissue integrity, investigators frequently compare Vilon's fibroblast-modulating capacity against BPC-157 tissue studies, which operate via VEGFR2 signaling and focal adhesion kinase activation. Laboratory teams evaluating multiple targets can review these distinct pathways when sourcing compounds from our product library.

Laboratory Handling, Reconstitution, and Storage Specifications

Vilon is supplied by PX1 Research as a lyophilized (freeze-dried) powder in sealed, sterile glass vials to ensure long-term chemical stability. To maintain compound integrity, intact vials must be stored in a freezer at -20°C or below, protected from light and moisture ingress. Under these conditions, the un-reconstituted compound remains stable for up to 24 months.

Reconstitution should be performed under aseptic laboratory conditions using sterile bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4). After introducing the diluent down the glass vial wall, gentle swirly rotation should be employed to achieve complete dissolution; physical vortexing or vigorous agitation should be avoided to prevent mechanical shearing or peptide denaturation.

Once reconstituted, working aliquots should be divided into sterile, low-protein-binding microcentrifuge tubes to prevent adsorption loss. Reconstituted Vilon solutions should be stored at 4°C for short-term experimentation (up to 7 days) or stored at -80°C for extended research periods. Repeated freeze-thaw cycles must be strictly avoided as they induce peptide degradation and compromise concentration accuracy in downstream assays.

Vendor Qualification Criteria for Sourcing Vilon

Selecting a reliable supplier for Vilon requires rigorous auditing of quality assurance protocols and manufacturing standards. Because short dipeptides can easily suffer from truncated sequences, residual trifluoroacetic acid (TFA) contamination, or moisture absorption, institutional procurement departments must demand transparent analytical metrics prior to placing orders.

Key evaluation factors for a qualified Vilon supplier include:

1. Verified USA Manufacturing: Ensures adherence to strict standard operating procedures and domestic regulatory oversight.

2. Lot-Specific Analytical Verification: Every batch must be paired with independent test documentation detailing chemical structure and purity.

3. High-Performance Liquid Chromatography (RP-HPLC): Confirms peptide purity levels meet or exceed 98%, ensuring absence of related peptide impurities.

4. Mass Spectrometry (MS): Confirms exact molecular mass (275.31 g/mol) to verify sequence accuracy without ambiguity.

5. Quantitative Endotoxin Testing: Guarantees endotoxin levels remain below strictly controlled limits (<0.01 EU/μg) to avoid confounding cell culture assays.

Quality Assurance Standard: PX1 Research Testing & Verification

PX1 Research sets the benchmark for laboratory-grade peptide supply by subjecting every lot of Vilon to rigorous third-party testing in ISO 17025 accredited analytical laboratories operating in GMP-compliant facilities. We do not rely on generic manufacturer statements; our quality control protocols require independent validation for every single production run.

Our high-performance liquid chromatography (RP-HPLC) testing confirms analytical purity levels of ≥98%, ensuring that contaminants such as truncated sequences or residual processing reagents do not corrupt your experimental outcomes. Furthermore, matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF) or LC-MS is performed on every lot to verify precise molecular weight and structural identity.

To safeguard sensitive in vitro cultures and animal models against inflammatory artifacts, PX1 Research performs quantitative Chromogenic LAL endotoxin assays on all Vilon batches, verifying endotoxin content strictly below 0.01 EU/μg. Institutional clients can access downloadable, lot-traceable COAs directly through our portal to maintain flawless laboratory audit trails.

Institutional Procurement and Wholesale Vilon Sourcing

For academic institutions, biotechnology enterprises, and clinical research organizations conducting large-scale preclinical studies, PX1 Research provides streamlined institutional purchasing options through our bulk research procurement program. We accommodate high-volume requirements with consistent lot-to-lot uniformity and custom vial sizing upon request.

All orders placed with PX1 Research are fulfilled rapidly from our primary logistics hubs located in California and Arizona, with same-day shipping offered Monday through Friday for orders placed before cutoff times. Our domestic distribution network eliminates international customs delays and cold-chain disruptions, ensuring that your research facilities receive stable, high-grade reagents precisely when required.

Frequently Asked Questions

What is Vilon and what is its molecular weight?

Vilon is a synthetic bi-peptide composed of L-lysine and L-glutamic acid (Lys-Glu). It has an exact molecular weight of 275.31 g/mol and is studied in preclinical research for its effects on chromatin structure and gene expression.

What is the purity standard of PX1 Research Vilon?

PX1 Research Vilon is verified to have an analytical purity of ≥98% using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS).

How is Vilon tested for bacterial endotoxins?

Every lot of Vilon undergoes quantitative Chromogenic Limulus Amebocyte Lysate (LAL) testing at an ISO 17025 accredited laboratory to verify endotoxin levels are strictly less than 0.01 EU/μg.

What solvent should be used to reconstitute Vilon for laboratory assays?

Vilon is typically reconstituted using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) under aseptic conditions depending on downstream in vitro assay specifications.

How should reconstituted Vilon be stored in the lab?

Reconstituted Vilon solutions should be split into single-use aliquots to prevent freeze-thaw cycles and stored at 4°C for up to 7 days, or -80°C for long-term storage.

Is Vilon intended for therapeutic or human use?

No. Vilon supplied by PX1 Research is strictly for laboratory research and in vitro or preclinical animal experimentation. It is not for human or veterinary use, therapy, or clinical application.

Where does PX1 Research ship Vilon from?

PX1 Research ships all research compounds directly from domestic fulfillment facilities in California and Arizona, offering same-day dispatch Monday through Friday.

How does Vilon differ from Epitalon in research models?

Vilon is a dipeptide (Lys-Glu) primarily evaluated for localized chromatin uncoiling and basic immune cell expression, whereas Epitalon is a tetrapeptide (Ala-Glu-Asp-Gly) studied for pineal gland regulation and telomerase activity.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.